Aterian Inc vs Novartis AG — how do they compare? Aterian Inc trades at $0.48 (market cap $5.32M), while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG is far larger — about 55520.7× Aterian Inc's market cap, and Novartis AG pays a 3.07% dividend while Aterian Inc pays none. Which is the better fit depends on your goals.
| ATER | NVS | |
|---|---|---|
Market Cap | $5.32M | $295.37B |
Sector | Consumer Cyclical | Health |
52-Week High | $1.39 | $168.62 |
52-Week Low | $0.36 | $119.31 |
Enterprise Value | $5.90M | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
Read more on ATER →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →